| retracted paper | Q45182324 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034750040 |
| P356 | DOI | 10.1007/S10549-015-3274-X |
| P698 | PubMed publication ID | 25616356 |
| P2860 | cites work | Triple-negative breast cancer: therapeutic options | Q36747692 |
| Genetic susceptibility to triple-negative breast cancer | Q36846498 | ||
| Cancer cell killing via ROS: to increase or decrease, that is the question | Q37316371 | ||
| Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth | Q37589159 | ||
| Histological and molecular types of breast cancer: is there a unifying taxonomy? | Q37639896 | ||
| Metabolic control analysis of mammalian serine metabolism | Q37825022 | ||
| RETRACTED: Quercetin suppresses insulin receptor signaling through inhibition of the insulin ligand-receptor binding and therefore impairs cancer cell proliferation | Q38954654 | ||
| Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. | Q39225768 | ||
| Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis | Q39721070 | ||
| Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. | Q39912742 | ||
| The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays | Q40240269 | ||
| The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species. | Q40477993 | ||
| Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways | Q44822086 | ||
| Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin | Q46857381 | ||
| Genetic selection for enhanced serine metabolism in cancer development. | Q53207576 | ||
| RETRACTED: Identification of an antitumor immune response of polyhistidine through a toll-like receptor 4-dependent manner. | Q64970193 | ||
| Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes | Q79323417 | ||
| Doxorubicin cardiomyopathy | Q24606920 | ||
| Targeting triple-negative breast cancer: optimising therapeutic outcomes | Q26850892 | ||
| Serine is a natural ligand and allosteric activator of pyruvate kinase M2 | Q27674495 | ||
| Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? | Q29616804 | ||
| Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
| Triple-negative breast cancer: role of specific chemotherapy agents | Q33900930 | ||
| Functional genomics reveal that the serine synthesis pathway is essential in breast cancer | Q34200610 | ||
| Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis | Q34205126 | ||
| Identification of the molecular basis of doxorubicin-induced cardiotoxicity | Q34308627 | ||
| Locoregional treatment outcomes after multimodality management of inflammatory breast cancer | Q34584856 | ||
| Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes | Q35895750 | ||
| P433 | issue | 2 | |
| P921 | main subject | doxorubicin | Q18936 |
| triple-negative breast cancer | Q7843332 | ||
| P304 | page(s) | 477 | |
| P577 | publication date | 2015-01-24 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | RETRACTED ARTICLE: Enhancement of doxorubicin efficacy through suppression of serine synthesis in triple-negative breast cancer | |
| P478 | volume | 151 |
Search more.